Catalogue, cause, complexity and cure; the many uses of cancer genome sequence.
暂无分享,去创建一个
[1] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[2] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[3] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[4] Gurpreet W. Tang,et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes , 2009, Nature.
[5] J. Bartek,et al. The DNA-damage response in human biology and disease , 2009, Nature.
[6] Ryan D. Morin,et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.
[7] Ken Chen,et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. , 2009, The New England journal of medicine.
[8] David T. W. Jones,et al. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. , 2009, Neuro-oncology.
[9] P. Kleihues,et al. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. , 2009, The American journal of pathology.
[10] J. Teague,et al. Somatic mutation databases as tools for molecular epidemiology and molecular pathology of cancer: Proposed guidelines for improving data collection, distribution, and integration , 2009, Human mutation.
[11] A. Marchetti,et al. IDH1 mutations at residue p.R132 (IDH1R132) occur frequently in high‐grade gliomas but not in other solid tumors , 2009, Human mutation.
[12] Amy E. Hawkins,et al. DNA sequencing of a cytogenetically normal acute myeloid leukemia genome , 2008, Nature.
[13] Brian H. Dunford-Shore,et al. Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.
[14] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[15] Robert A Beckman,et al. Cancers exhibit a mutator phenotype: clinical implications. , 2008, Cancer research.
[16] Derek Y. Chiang,et al. Characterizing the cancer genome in lung adenocarcinoma , 2007, Nature.
[17] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[18] S. Dhanasekaran,et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.
[19] Rebecca A Betensky,et al. Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment. , 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.
[20] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[21] S. Gabriel,et al. High-throughput oncogene mutation profiling in human cancer , 2007, Nature Genetics.
[22] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[23] Tracy T Batchelor,et al. A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy. , 2006, Cancer research.
[24] Richard Lugg,et al. Sequence analysis of the protein kinase gene family in human testicular germ‐cell tumors of adolescents and adults , 2006, Genes, chromosomes & cancer.
[25] Andrew D. Yates,et al. Somatic mutations of the protein kinase gene family in human lung cancer. , 2005, Cancer research.
[26] Andrew D. Yates,et al. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer , 2005, Nature Genetics.
[27] Giovanni Parmigiani,et al. Mutational Analysis of the Tyrosine Phosphatome in Colorectal Cancers , 2004, Science.
[28] J. Ptak,et al. High Frequency of Mutations of the PIK3CA Gene in Human Cancers , 2004, Science.
[29] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[30] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[31] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[32] Gurpreet W. Tang,et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer , 2010, Nucleic Acids Res..
[33] M. Metzker. Sequencing technologies — the next generation , 2010, Nature Reviews Genetics.
[34] M. Olivier,et al. Recent advances in p53 research: an interdisciplinary perspective , 2009, Cancer Gene Therapy.
[35] Amy E. Hawkins,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2022 .
[36] J. Uhm. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2009 .
[37] Derek Y. Chiang,et al. High-resolution mapping of copy-number alterations with massively parallel sequencing , 2009, Nature Methods.
[38] Giovanni Parmigiani,et al. Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers , 2003, Nature Reviews Cancer.